Cervical cancer, primarily caused by high-risk human papillomavirus (HPV) subtypes 16 and 18, remains a global health challenge, particularly in resource-limited regions where HPV vaccine accessibility is constrained by cost and logistical barriers. This study... ...

请注册登录后继续浏览